Journal
SEMINARS IN PEDIATRIC SURGERY
Volume 26, Issue 3, Pages 171-177Publisher
ELSEVIER SCIENCE INC
DOI: 10.1053/j.sempedsurg.2017.04.009
Keywords
Congenital diaphragmatic hernia; Cell therapy; Tissue engineering; Pulmonary hypoplasia; Patch repair
Categories
Funding
- Catapult Cell Therapy
- GOSHCC
- GOSH NIHR Biomedical Research Centre's funding scheme
- Wellcome Trust, United Kingdom [WT101957]
- Engineering and Physical Sciences Research Council (EPSRC), United Kingdom [NS/A000027/1]
- Fetal Health Foundation (USA)
- National Institute for Health Research [RP_2014-04-046] Funding Source: researchfish
Ask authors/readers for more resources
Congenital diaphragmatic hernia (CDH) remains a major challenge and associated mortality is still significant. Patients have benefited from current therapeutic options, but most severe cases are still associated to poor outcome. Regenerative medicine is emerging as a valid option in many diseases and clinical trials are currently happening for various conditions in children and adults. We report here the advancement in the field which will help both in the understanding of further CDH development and in offering new treatment options for the difficult situations such as repair of large diaphragmatic defects and lung hypoplasia. The authors believe that advancements in regenerative medicine may lead to increase of CDH patients' survival. (C) 2017 Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available